For oncologists, complete biomarker testing is becoming increasingly important before starting treatment for advanced lung cancer patients. Do not proceed with first-line therapy without a clear view ahead. Liquid biopsies such as the Guardant360 test allow physicians to see the most current genomic profile of their patient’s tumor and recommend appropriate treatment. Find out more about this initiative at https://clearyourview.org.
Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at firstname.lastname@example.org or contact us on WhatsApp: +65 8940 0360.
Guardant360®. Test. Take Action.